Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 4/20 | 0.36 |
| ▸ | ICMT | O60725 | 2/20 | 0.34 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 2/20 | 0.32 |
| ▸ | CDC25A | P30304 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP9 | P14780 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | MMP13 | P45452 | 2/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25444689 | 1.00 | PDK2 (0.36) | PDK2ICMTSLC9A1PTPN11CES1 | |
| SCHEMBL25444636 | 0.87 | ICMT (0.33) | ICMTMMP2MMP9MMP8MMP13 | |
| SCHEMBL25444687 | 0.85 | PDK2 (0.40) | PDK2PTPN11 | |
| SCHEMBL1994589 | 0.84 | PDK2 (0.41) | PDK2PTPN11MMP2MMP9MMP8 | |
| SCHEMBL15957308 | 0.83 | PDK2 (0.33) | PDK2 | |
| SCHEMBL5354304 | 0.83 | PDK2 (0.37) | PDK2PTPN11MMP2MMP9MMP8 | |
| SCHEMBL22402534 | 0.83 | PDK2 (0.37) | PDK2PTPN11MMP2MMP9MMP8 | |
| SCHEMBL25444633 | 0.83 | PDK2 (0.37) | PDK2PTPN11MMP2MMP9MMP8 | |
| SCHEMBL25444635 | 0.83 | PDK2 (0.37) | PDK2PTPN11MMP2MMP9MMP8 | |
| SCHEMBL25444697 | 0.82 | PDK2 (0.37) | PDK2PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230143779-A1 | ORGANIC SOLID-STATE LASER, COMPOUND AND USE THEREOF | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143779-A1 | ORGANIC SOLID-STATE LASER, COMPOUND AND USE THEREOF | LEF1, CCNT1, CCNT2 | PDK2 3407/4885ICMT 2909/4885SLC9A1 3618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.